Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) FCF Margin (2016 - 2025)

Historic FCF Margin for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to 1.97%.

  • Cumberland Pharmaceuticals' FCF Margin fell 30900.0% to 1.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.31%, marking a year-over-year increase of 206300.0%. This contributed to the annual value of 1.79% for FY2024, which is 164900.0% down from last year.
  • Cumberland Pharmaceuticals' FCF Margin amounted to 1.97% in Q3 2025, which was down 30900.0% from 7.54% recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year FCF Margin high stood at 47.42% for Q2 2023, and its period low was 25.63% during Q1 2024.
  • Its 5-year average for FCF Margin is 12.42%, with a median of 11.73% in 2023.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' FCF Margin plummeted by -561800bps in 2024, and later skyrocketed by 585100bps in 2025.
  • Quarter analysis of 5 years shows Cumberland Pharmaceuticals' FCF Margin stood at 23.45% in 2021, then skyrocketed by 77bps to 41.56% in 2022, then crashed by -74bps to 10.6% in 2023, then skyrocketed by 72bps to 18.23% in 2024, then tumbled by -89bps to 1.97% in 2025.
  • Its FCF Margin stands at 1.97% for Q3 2025, versus 7.54% for Q2 2025 and 32.88% for Q1 2025.